Cognetivity Neurosciences Ltd.
CGN
CNSX
| 10/31/2023 | 07/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 41.45% | 390.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 41.45% | 390.32% | |||
| Cost of Revenue | 24.41% | -31.21% | |||
| Gross Profit | -23.45% | 34.40% | |||
| SG&A Expenses | -10.95% | 7.24% | |||
| Depreciation & Amortization | -10.53% | 11.76% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.43% | -19.63% | |||
| Operating Income | 0.50% | 21.16% | |||
| Income Before Tax | -3.40% | 6.77% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.40% | 6.77% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.40% | 6.77% | |||
| EBIT | 0.50% | 21.16% | |||
| EBITDA | 0.43% | 21.37% | |||
| EPS Basic | -1.80% | 8.24% | |||
| Normalized Basic EPS | 1.77% | -1.80% | |||
| EPS Diluted | -1.80% | 8.24% | |||
| Normalized Diluted EPS | 1.77% | -1.80% | |||
| Average Basic Shares Outstanding | 1.48% | 1.66% | |||
| Average Diluted Shares Outstanding | 1.48% | 1.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
